Barbiturates can induce hepatic microsomal enzymes resulting in greater metabolism and reduced anticoagulant response of oral anticoagulants (eg, warfarin, acenocoumarol, dicumarol, and phenprocoumon); individuals stabilized on anticoagulant therapy could involve dosage adjustments if barbiturates are extra to or withdrawn from their dosage program